PDCD1 and cancer: Although the blockade of adenosine receptors increases the efficacy of anti-PD-1 and modulates the immune response [25,26,27,28,29], only a few studies have investigated the effects of cordycepin on immune checkpoint inhibitors, as well as the efficacy of combined anti-cancer treatment with cordycepin and immune checkpoint inhibitors.